DK0462277T3 - Glycoprotein af human oprindelse, fysiologisk aktiv faktor omfattende dette og farmaceutisk præparat indeholdende dette som aktiv ingrediens - Google Patents

Glycoprotein af human oprindelse, fysiologisk aktiv faktor omfattende dette og farmaceutisk præparat indeholdende dette som aktiv ingrediens

Info

Publication number
DK0462277T3
DK0462277T3 DK90904429.9T DK90904429T DK0462277T3 DK 0462277 T3 DK0462277 T3 DK 0462277T3 DK 90904429 T DK90904429 T DK 90904429T DK 0462277 T3 DK0462277 T3 DK 0462277T3
Authority
DK
Denmark
Prior art keywords
glycoprotein
human origin
pharmaceutical composition
composition containing
active ingredient
Prior art date
Application number
DK90904429.9T
Other languages
English (en)
Inventor
Kanji Higashio
Shinjiro Mitsuda
Nobuyuki Shima
Yasuharu Itagaki
Masaya Nagao
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26340889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0462277(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of DK0462277T3 publication Critical patent/DK0462277T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90904429.9T 1989-03-10 1990-03-09 Glycoprotein af human oprindelse, fysiologisk aktiv faktor omfattende dette og farmaceutisk præparat indeholdende dette som aktiv ingrediens DK0462277T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5863189 1989-03-10
JP669290 1990-01-16

Publications (1)

Publication Number Publication Date
DK0462277T3 true DK0462277T3 (da) 1995-10-30

Family

ID=26340889

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90904429.9T DK0462277T3 (da) 1989-03-10 1990-03-09 Glycoprotein af human oprindelse, fysiologisk aktiv faktor omfattende dette og farmaceutisk præparat indeholdende dette som aktiv ingrediens

Country Status (17)

Country Link
US (2) US5587359A (da)
EP (1) EP0462277B1 (da)
JP (1) JPH0768272B2 (da)
KR (1) KR960009054B1 (da)
AT (1) ATE123498T1 (da)
AU (1) AU629314B2 (da)
CA (1) CA2049017C (da)
DE (1) DE69019962T2 (da)
DK (1) DK0462277T3 (da)
ES (1) ES2075199T3 (da)
FI (1) FI102681B1 (da)
HU (2) HU212513B (da)
IE (1) IE64005B1 (da)
NO (1) NO180796C (da)
NZ (1) NZ232813A (da)
RU (1) RU2113480C1 (da)
WO (1) WO1990010651A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
DE69133492T2 (de) * 1990-06-11 2006-08-10 Nakamura, Toshikazu Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
ATE178354T1 (de) * 1990-07-13 1999-04-15 Snow Brand Milk Products Co Ltd Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung
ATE256736T1 (de) * 1990-09-14 2004-01-15 Us Health Ein nicht-mitogener kompetitiver hgf-antagonist
US5821223A (en) * 1990-09-14 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
JP3200609B2 (ja) * 1990-12-28 2001-08-20 敏一 中村 上皮細胞増殖促進剤
JPH0597A (ja) * 1991-06-21 1993-01-08 Snow Brand Milk Prod Co Ltd 新規抗ｔｃｆ−ｉｉモノクローナル抗体及びそれを用いるｔｃｆ−ｉｉの測定方法
AU674871B2 (en) * 1992-07-16 1997-01-16 Atlas Pharmaceuticals Inc. Blood coagulation normalizer containing TCF-II as active ingredient
DK0588477T3 (da) * 1992-07-16 1998-03-30 Snow Brand Milk Products Co Ltd Medicinsk præparat omfatende TCF-11
JP3380573B2 (ja) 1992-07-16 2003-02-24 第一製薬株式会社 Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
WO1994014845A1 (en) * 1992-12-28 1994-07-07 Snow Brand Milk Products Co., Ltd. Modified tcf
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤
US5837676A (en) * 1993-10-18 1998-11-17 Long Island Jewish Medical Center Use of scatter factor to enhance angiogenesis
JP2747979B2 (ja) * 1994-08-19 1998-05-06 雪印乳業株式会社 ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬
NZ298141A (en) * 1994-12-27 2000-12-22 Snow Brand Milk Products Co Ltd Treating lipid metabolism disorder using TCF-II
DE69531673T2 (de) * 1994-12-27 2004-07-08 Daiichi Pharmaceutical Co., Ltd. Tcf mutante
AU4027601A (en) * 1995-07-11 2001-07-26 Snow Brand Milk Products Co., Ltd. Lyophilized HGF preparations
JP3927248B2 (ja) * 1995-07-11 2007-06-06 第一製薬株式会社 Ｈｇｆ凍結乾燥製剤
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ES2274567T3 (es) 1997-03-14 2007-05-16 Daiichi Pharmaceutical Co., Ltd. Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤
JPH11269091A (ja) * 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び／又は治療剤
CN1352087A (zh) * 2000-11-02 2002-06-05 上海博德基因开发有限公司 一种新的多肽——人糖蛋白42和编码这种多肽的多核苷酸
KR100562824B1 (ko) 2002-03-20 2006-03-23 주식회사 바이로메드 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
CN100417412C (zh) * 2003-03-28 2008-09-10 威海赛洛金药业有限公司 促肝细胞生长素注射液及制备方法和应用
US20060199762A1 (en) * 2003-09-03 2006-09-07 Toshikazu Nakamura Skin ulcer preventive curative agent containing human recombinant hgf
EP1987054A1 (en) * 2006-01-25 2008-11-05 Octapharma AG Purification and use of a factor for supporting wound healing
WO2008136183A1 (ja) * 2007-04-28 2008-11-13 Applied Cell Biotechnologies, Inc. 皮膚または歯肉の軟組織の欠損を補修するための組成物，及び自己線維芽細胞の培養方法
US20090202606A1 (en) * 2008-01-25 2009-08-13 Viromed Co., Ltd. Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
KR101290322B1 (ko) * 2008-04-09 2013-07-26 주식회사 바이로메드 플라스미드 ｄｎａ의 발현 증강용 동결건조 ｄｎａ 제제
JP6240337B2 (ja) 2013-10-22 2017-11-29 バイロメッド カンパニー リミテッド 肝細胞増殖因子の２つ以上のアイソフォームを利用した筋萎縮性側索硬化症の予防又は治療用組成物
CA2947396C (en) 2014-04-28 2021-10-19 Eisai R&D Management Co., Ltd. Lyophilized formulation of hgf
WO2016039163A1 (ja) 2014-09-10 2016-03-17 クリングルファーマ株式会社 神経疾患の治療に適したｈｇｆ製剤
RU2747977C2 (ru) 2016-03-17 2021-05-18 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Способ получения активного фактора роста гепатоцитов (hgf)
AU2019305221B2 (en) 2018-07-19 2024-11-07 Helixmith Co., Ltd. Lyophilized pharmaceutical compositions for naked DNA gene therapy
IL308496A (en) 2021-05-14 2024-01-01 Claris Biotherapeutics Inc Growth factor compounds for the treatment of eye diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58148826A (ja) * 1982-02-26 1983-09-05 Mochida Pharmaceut Co Ltd 糖蛋白質および腫瘍治療剤
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
DE3643182A1 (de) * 1986-12-18 1988-06-30 Behringwerke Ag Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4
JPS6410998A (en) * 1986-12-22 1989-01-13 Green Cross Corp Tumor cell inhibitory factor
JPS63243032A (ja) * 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
JPH0741891B2 (ja) * 1987-08-26 1995-05-10 凸版印刷株式会社 容器素材成形装置
FI80741C (fi) * 1987-10-29 1990-07-10 Laennen Tehtaat Oy Modifierat papper.
ATE178354T1 (de) * 1990-07-13 1999-04-15 Snow Brand Milk Products Co Ltd Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung

Also Published As

Publication number Publication date
EP0462277B1 (en) 1995-06-07
HUT58797A (en) 1992-03-30
FI102681B (fi) 1999-01-29
ES2075199T3 (es) 1995-10-01
DE69019962D1 (de) 1995-07-13
HU212513B (en) 1996-07-29
CA2049017A1 (en) 1990-09-11
AU5177490A (en) 1990-10-09
FI914234A0 (fi) 1991-09-09
NO913546D0 (no) 1991-09-09
JPH0768272B2 (ja) 1995-07-26
CA2049017C (en) 1998-10-27
WO1990010651A1 (en) 1990-09-20
RU95110767A (ru) 1997-06-10
EP0462277A1 (en) 1991-12-27
RU2113480C1 (ru) 1998-06-20
EP0462277A4 (en) 1992-08-12
KR960009054B1 (ko) 1996-07-10
NZ232813A (en) 1992-08-26
US5587359A (en) 1996-12-24
JPH0768272B1 (da) 1995-07-26
HU902330D0 (en) 1991-12-30
KR920701256A (ko) 1992-08-11
AU629314B2 (en) 1992-10-01
ATE123498T1 (de) 1995-06-15
FI102681B1 (fi) 1999-01-29
NO180796C (no) 1997-06-25
IE900863L (en) 1990-09-10
US6333309B1 (en) 2001-12-25
IE64005B1 (en) 1995-06-28
DE69019962T2 (de) 1995-11-23
NO180796B (no) 1997-03-17
NO913546L (no) 1991-11-11
HU211229A9 (en) 1995-11-28

Similar Documents

Publication Publication Date Title
NO913546D0 (no) Glykoprotein av human opprinnelse, fysiologisk aktiv faktor som omfatter glykoproteinet, og farmasoeytisk preparat som inneholder faktoren som aktiv bestanddel.
MX9203439A (es) Una citocina mamifera, il-11
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
DE69331739D1 (de) Neuartige pharmazeutische verwendungen von krill-enzymen
EP1535929A3 (en) Megakaryocyte stimulating factors
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
ATE183751T1 (de) Zytotoxische zyklische depsipeptide des manteltierchen trididemnum solidum
DE59101214D1 (de) Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich.
DE59001121D1 (en) Antacidatabletten.
ES2078253T3 (es) Sintetasa de la sustancia ron biologicamente activa y su uso para producir sustancia ron biologicamente activa.
ES2019025A6 (es) Procedimiento para preparar una composicion farmaceutica liquida de desmopresina.
IE871358L (en) Interferon for carcinoma
EP0264017A3 (en) Pharmaceutical compositions having healing activity